Experimental endotoxemia as a model to study neuroimmune mechanisms in human visceral pain

Annals of the New York Academy of Sciences

Volumn 1262, Issue 1, 2012, Pages 108-117

  Benson, Sven ^a   Engler, Harald ^a   Schedlowski, Manfred ^a   Elsenbruch, Sigrid ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cytokines; Endotoxemia; Hyperalgesia; Irritable bowel syndrome; Lipopolysaccharide; Visceral pain

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANTERIOR CINGULATE; ARTICLE; BLOOD BRAIN BARRIER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENDOTOXEMIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERALGESIA; ILLNESS BEHAVIOR; IMMUNOMODULATION; IRRITABLE COLON; NEUROIMMUNOLOGY; NONHUMAN; SOLITARY TRACT NUCLEUS; VAGUS NERVE; VISCERAL PAIN;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 84864140643     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06622.x     Document Type: Article

References (91)

1. Knowles, C.H. & Q. Aziz. 2009. Basic and clinical aspects of gastrointestinal pain. Pain 141: 191-209.
2. Akbar, A., J.R.F. Walters & S. Ghosh. 2009. Review article: visceral hypersensitivity in irritable bowel syndrome. Molecular mechanisms and therapeutic agents. Alimentary Pharmacol. Therapeutics 30: 423-435.
3. Wilder-Smith, C.H. 2011. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. Gut 60: 1589-1599.
4. Longstreth, G.F., W.G. Thompson, W.D. Chey, et al. 2006. Functional bowel disorders. Gastroenterology 130: 1480-1491.
5. Jones, R. & S. Lydeard. 1992. Irritable-bowel-syndrome in the general-population. Br. Med. J. 304: 87-90.
6. Talley, N.J., A.R. Zinsmeister, C. Vandyke & L.J. Melton. 1991. Epidemiology of colonic symptoms and the irritable-bowel-syndrome. Gastroenterology 101: 927-934.
7. Mitchell, C.M. & D.A. Drossman. 1987. Survey of the aga membership relating to patients with functional gastrointestinal disorders. Gastroenterology 92: 1282-1284.
8. Talley, N.J. 2008. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol. Motility 20: 121-129.
9. Elsenbruch, S. 2011. Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav. Immun. 25: 386-394.
10. Bercik, P., E.F. Verdu & S.M. Collins. 2005. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol. Clin. N. Am. 34: 235-245.
11. O'Malley, D., E.M.M. Quigleya, T.G. Dinana & J.F. Cryana. 2011. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain Behav. Immun. 25: 1333-1341.
12. Spiller, R.C. 2009. Overlap between irritable bowel syndrome and inflammatory bowel disease. Digestive Dis. 27: 48-54.
13. Collins, S.M., T. Piche & P. Rampal. 2001. The putative role of inflammation in the irritable bowel syndrome. Gut 49: 743-745.
14. Spiller, R. & K. Garsed. 2009. Postinfectious irritable bowel syndrome. Gastroenterology 136: 1979-1988.
15. Spiller, R.C., D. Jenkins, J.P. Thornley, et al. 2000. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47: 804-811.
16. Halvorson, H.A., C.D. Schlett & M.S. Riddle. 2006. Postinfectious irritable bowel syndrome-a meta-analysis. Am. J. Gastroenterol. 101: 1894-1899.
17. Thabane, M., D.T. Kottachchi & J.K. Marshall. 2007. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Alimentary Pharmacol. Therapeutics 26: 535-544.
18. Bergin, A.J., T.C. Donnelly, M.W. McKendrick & N.W. Read. 1993. Changes in anorectal function in persistent bowel disturbance following salmonella gastroenteritis. Eur. J. Gastroenterol. Hepatol. 5: 617-620.
19. Gwee, K.A., Y.L. Leong, C. Graham, et al. 1999. The role of psychological and biological factors in postinfective gut dysfunction. Gut 44: 400-406.
20. Mearin, F., A. Perello, A. Balboa, et al. 2009. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scandinavian J. Gastroenterol. 44: 1173-1185.
21. Al-Khatib, K. & H.C. Lin. 2009. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver 3: 14-19.
22. Collins, S.M. & P. Bercik. 2009. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136: 2003-2014.
23. Adam, B., T. Liebregts, J.M. Gschossmann, et al. 2006. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain 123: 179-186.
24. Zhou, Q., B. Zhang & G.N. Verne. 2009. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 146: 41-46.
25. Dinan, T.G., G. Clarke, E.M.M. Quigley, et al. 2008. Enhanced cholinergic-mediated increase in the proinflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am. J. Gastroenterol. 103: 2570-2576.
26. Liebregts, T., B. Adam, C. Bredack, et al. 2007. Immune activation in patients with irritable bowel syndrome. Gastroenterology 132: 913-920.
27. Hod, K., R. Dickman, A. Sperber, et al. 2011. Assessment of high-sensitivity crp as a marker of micro-inflammation in irritable bowel syndrome. Neurogastroenterol. Motility 23: 1105-1110.
28. Holzer, P. 2002. Sensory neurone responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain. Neurogastroenterol. Motility 14: 459-475.
29. Engler, H., R. Doenlen, A. Engler, et al. 2011. Acute amygdaloid response to systemic inflammation. Brain Behav. Immun. 25: 1384-1392.
30. Dantzer, R., J.C. O'Connor, G.G. Freund, et al. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev. Neurosci. 9: 46-57.
31. Raison, C.L., L. Capuron & A.H. Miller. 2006. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27: 24-31.
32. Sternberg, E.M. 2006. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Rev. Immunol. 6: 318-328.
33. Kent, S., R.M. Bluthe, K.W. Kelley & R. Dantzer. 1992. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13: 24-28.
34. Cunningham, C., S. Campion, K. Lunnon, et al. 2009. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatr. 65: 304-312.
35. Sparkman, N.L., R.A. Kohman, A.K. Garcia & G.W. Boehm. 2005. Peripheral lipopolysaccharide administration impairs two-way active avoidance conditioning in c57bl/6j mice. Physiol. Behav. 85: 278-288.
36. DellaGioia, N. & J. Hannestad. 2010. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci. Biobehav. Rev. 34: 130-143.
37. Kullmann, J.S., J.-S. Grigoleit & M. Schedlowski. 2011. Effects of an acute inflammation on memory performance, mood and brain activity. Zeitschrift fuer Medizinische Psychologie 20: 108-117.
38. Maier, S.F. & L.R. Watkins. 2003. Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain Behav. Immun. 17: S125-S131.
39. Watkins, L.R. & S.F. Maier. 2005. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J. Intern. Med. 257: 139-155.
40. Ueceyler, N., M. Schaefers & C. Sommer. 2009. Mode of action of cytokines on nociceptive neurons. Exp. Brain Res. 196: 67-78.
41. Miller, R.J., H. Jung, S.K. Bhangoo & F.A. White. 2009. Cytokine and chemokine regulation of sensory neuron function. Handbook of Experimental Pharmacology, 417-449. Springer.
42. Kidd, B.L. & L.A. Urban. 2001. Mechanisms of inflammatory pain. Br. J. Anaesthesia 87: 3-11.
43. Ito, H. 2005. Treatment of crohn's disease with anti-IL-6 receptor antibody. J. Gastroenterol. 40: 32-34.
44. Fitzcharles, M.A., A. Almahrezi & Y. Shir. 2005. Pain-understanding and challenges for the rheumatologist. Arthritis Rheumatism 52: 3685-3692.
45. Akira, S. & K. Takeda. 2004. Toll-like receptor signalling. Nature Rev. Immunol. 4: 499-511.
46. Bahador, M. & A.S. Cross. 2007. From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J. Endotoxin Res. 13: 251-279.
47. Yirmiya, R. & I. Goshen. 2011. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25: 181-213.
48. Suffredini, A.F., H.D. Hochstein & F.G. McMahon. 1999. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J. Infect. Dis. 179: 1278-1282.
49. Reichenberg, A., R. Yirmiya, A. Schuld, et al. 2001. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatr. 58: 445-452.
50. Grigoleit, J.-S., J.R. Oberbeck, P. Lichte, et al. 2010. Lipopolysaccharide-induced experimental immune activation does not impair memory functions in humans. Neurobiol. Learn. Mem. 94: 561-567.
51. Grigoleit, J.-S., J.S. Kullmann, O.T. Wolf, et al. 2011. Dose-dependent effects of endotoxin on neurobehavioral functions in humans. PLoS ONE 6: e28330.
52. Krogh-Madsen, R., K. Moller, F. Dela, et al. 2004. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am. J. Physiol. Endocrinol. Metabol. 286: E766-E772.
53. Krabbe, K.S., A. Reichenberg, R. Yirmiya, et al. 2005. Low-dose endotoxemia and human neuropsychological functions. Brain Behav. Immun. 19: 453-460.
54. Eisenberger, N.I., E.T. Berkman, T.K. Inagaki, et al. 2010. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatr. 68: 748-754.
55. Eisenberger, N.I., T.K. Inagaki, N.M. Mashal & M.R. Irvin. 2010. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 24: 558-563.
56. Cohen, O., A. Reichenberg, C. Perry, et al. 2003. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase. J. Mol. Neurosci. 21: 199-212.
57. Watkins, L.R. & S.F. Maier. 2000. The pain of being sick: implications of immune-to-brain communication for understanding pain. Ann. Rev. Psychol. 51: 29-57.
58. Mason, P. 1993. Lipopolysaccharide induces fever and decreases tail-flick latency in awake rats. Neurosci. Lett. 154: 134-136.
59. Watkins, L.R., S.F. Maier & L.E. Goehler. 1995. Immune activation: the role of proinflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63: 289-302.
60. Loram, L.C., F.R. Taylor, K.A. Strand, et al. 2011. Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation. Brain Behav. Immun. 25: 1408-1415.
61. Benson, S., J. Kattoor, A. Wegner, et al. 2012. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 153: 382-390.
62. Benson, S., V. Kotsis, C. Rosenberger, et al. 2012. Behavioral and neural correlates of visceral pain sensitivity in healthy males and females: does sex matter? Eur. J. Pain 16: 349-358.
63. Elsenbruch, S., C. Rosenberger, U. Bingel, et al. 2010. Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli. Gastroenterology 139: 1310-1318.
64. Elsenbruch, S., C. Rosenberger, P. Enck, et al. 2010. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 59: 489-495.
65. Rosenberger, C., S. Elsenbruch, A. Scholle, et al. 2009. Effects of psychological stress on the cerebral processing of visceral stimuli in healthy women. Neurogastroenterol. Motility 21: E740-E745.
66. Kullmann, J.S., J.-S. Grigoleit, P. Lichte, et al. 2012. Neural response to emotional stimuli during experimental human endotoxemia. Hum. Brain Mapp. Mar 28. doi: [Epub ahead of print].
67. Gardiner, K.R., M.I. Halliday, G.R. Barclay, et al. 1995. Significance of systemic endotoxemia in inflammatory bowel-disease. Gut 36: 897-901.
68. Pastor Rojo, O., A. Lopez San Roman, E. Albeniz Arbizu, et al. 2007. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm. Bowel Dis. 13: 269-277.
69. Coelho, A.M., J. Fioramonti & L. Bueno. 2000. Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve. Am. J. Physiol.-Gastrointestinal Liver Physiol. 279: G781-G790.
70. Coelho, A.M., J. Fioramonti & L. Bueno. 2000. Brain interleukin-1 beta and tumor necrosis factor-alpha are involved in lipopolysaccharide-induced delayed rectal allodynia in awake rats. Brain Res. Bull. 52: 223-228.
71. Liu, C.Y., W. Jiang, M.H. Muller, et al. 2005. Sensitization of mesenteric afferents to chemical and mechanical stimuli following systemic bacterial lipopolysaccharide. Neurogastroenterol. Motility 17: 89-101.
72. Mayer, E.A. 2011. Gut feelings: the emerging biology of gut-brain communication. Nature Rev. Neurosci. 12: 453-466.
73. Furness, J.B., W.A.A. Kunze, P.P. Bertrand, et al. 1998. Intrinsic primary afferent neurons of the intestine. Prog. Neurobiol. 54: 1-18.
74. Gold, M.S. & G.F. Gebhart. 2010. Nociceptor sensitization in pain pathogenesis. Nature Med. 16: 1248-1257.
75. Barbara, G., V. Stanghellini, R. De Giorgio, et al. 2004. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126: 693-702.
76. Barbara, G., B. Wang, V. Stanghellini, et al. 2007. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132: 26-37.
77. Akbar, A., Y. Yiangou, P. Facer et al. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 57: 923-929.
78. Akbar, A., Y. Yiangou, P. Facer, et al. 2010. Expression of the trpv1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 59: 767-774.
79. Anand, P., Q. Aziz, R. Willert & L. Van Oudenhove. 2007. Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol. Motility 19: 29-46.
80. Goehler, L.E., M. Lyte & R.P.A. Gaykema. 2007. Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav. Immun. 21: 721-726.
81. Goehler, L.E., R.P.A. Gaykema, M.K. Hansen, et al. 2000. Vagal immune-to-brain communication: a visceral chemosensory pathway. Autonomic Neurosci. Basic Clin. 85: 49-59.
82. Gaykema, R.P.A., L.E. Goehler, et al. 1998. Bacterial endotoxin induces fos immunoreactivity in primary afferent neurons of the vagus nerve. Neuroimmunomodulation 5: 234-240.
83. Traub, R.J., J.N. Sengupta & G.F. Gebhart. 1996. Differential c-fos expression in the nucleus of the solitary tract and spinal cord following noxious gastric distention in the rat. Neuroscience 74: 873-884.
84. Zhang, J.H. & Y.G. Huang. 2006. The immune system: a new look at pain. Chinese Med. J. 119: 930-938.
85. Gaykema, R.P.A., L.E. Goehler & M. Lyte. 2004. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav. Immun. 18: 238-245.
86. Eisenberger, N.I., T.K. Inagaki, L.T. Rameson, et al. 2009. An fmri study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 47: 881-890.
87. Harrison, N.A., L. Brydon, C. Walker, et al. 2009. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatr. 66: 407-414.
88. Phan, K.L., T.D. Wager, S.F. Taylor & I. Liberzon. 2009. Functional neuroimaging studies of human emotions. CNS Spectrums 9: 258-266.
89. Azpiroz, F., M. Bouin, M. Camilleri, et al. 2007. Mechanisms of hypersensitivity in ibs and functional disorders. Neurogastroenterol. Motility 19: 62-88.
90. Wiech, K. & I. Tracey. 2009. The influence of negative emotions on pain: behavioral effects and neural mechanisms. NeuroImage 47: 987-994.
91. Tillisch, K., E.A. Mayer & J.S. Labus. 2011. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 140: 91-100.